| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/26/1990 | US4937079 Pharmaceutical composition for the prophylaxis and therapy of gastric ulcer |
| 06/26/1990 | US4937072 Mixing peroxide, peroxidase, iodide in aqueous solution |
| 06/26/1990 | US4937071 Method for augmenting immune response |
| 06/26/1990 | US4937070 Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids |
| 06/26/1990 | CA1270778A1 Hybrid cells secreting anti-idiotypic antibodies, monoclonal antibodies secreted by the said hybrid cells, their preparation and application |
| 06/26/1990 | CA1270623A1 Supercritical fluid extraction of animal derived material |
| 06/23/1990 | CA2006657A1 Repression of receptor transcriptional activity |
| 06/23/1990 | CA2006578A1 Human insulin analogues |
| 06/23/1990 | CA2006561A1 Retro-inverso analogues of thymopentin, the method for their synthesis and their use in the preparation of pharmaceutical compositions |
| 06/23/1990 | CA2006535A1 Cdna coding for placenta protein 11 (pp11), the isolation and use thereof |
| 06/23/1990 | CA2006443A1 Compounds |
| 06/23/1990 | CA2006437A1 Compounds |
| 06/23/1990 | CA2006383A1 Medicament comprising cyclolinopeptide a |
| 06/23/1990 | CA2005779A1 Biologically active whey protein composition, a method for producing it and use of the composition |
| 06/23/1990 | CA2005053A1 Tnf polypeptides |
| 06/22/1990 | CA2006496A1 Mammalian gap-43 compositions and methods of use |
| 06/22/1990 | CA2006353A1 Monoclonal antibody to human carcinomas |
| 06/22/1990 | CA2006268A1 Swelling-controlled oral delivery system for drugs |
| 06/22/1990 | CA2004571A1 Transdermal and intranasal administration of renin inhibitory peptides |
| 06/21/1990 | DE3844667A1 Use of transferrin for controlling the toxic effect of endotoxin in endotoxinaemia |
| 06/21/1990 | DE3842688A1 Use of somatostatin for the treatment of reactive post-prandial hypoglycaemias |
| 06/21/1990 | DE3842143A1 Verwendung von transferrin zur endotoxinneutralisation Use of transferrin to endotoxinneutralisation |
| 06/21/1990 | CA2006189A1 Derivatives of tetrapeptides as cck agonists |
| 06/20/1990 | EP0374120A2 Comosition for controlled release of polypeptides |
| 06/20/1990 | EP0374098A2 Inhibitors of retroviral proteases |
| 06/20/1990 | EP0374097A2 Use of peptide isosteres as retroviral protease inhibitors |
| 06/20/1990 | EP0374089A2 Use of somatostatin derivatives as lung protecting agents |
| 06/20/1990 | EP0374053A1 Medicine for the treatment or prevention by immunisation of an infection by HIV, and preparation processes |
| 06/20/1990 | EP0374044A2 TGF - beta 1 / beta 2 : a novel chimeric transforming growth factor-beta. |
| 06/20/1990 | EP0373994A1 Mutants of simian transforming growth factor-beta 1 |
| 06/20/1990 | EP0373916A2 Process for separation and concentration of apolipoproteins |
| 06/20/1990 | EP0373904A1 Process and composition for increasing brain dopamine release |
| 06/20/1990 | EP0373896A1 Novel thrombolytic proteins, process for producing the same, and drugs containing the same as active ingredient |
| 06/20/1990 | EP0373881A2 Process for preparing optically active 2-oxoimidazolidine derivatives |
| 06/20/1990 | EP0373771A2 New pharmaceutical uses for cystatins |
| 06/20/1990 | EP0373767A1 Anti-thrombins |
| 06/20/1990 | EP0373679A2 Stabilized hydrophobic protein formulations |
| 06/20/1990 | EP0373549A2 Amino acid derivatives with enzyme-inhibiting properties, process to synthetise them, composition containing them and their use |
| 06/20/1990 | EP0373545A2 Competitive genadoliberin antagonists |
| 06/20/1990 | EP0373540A2 Method for purifying fibroblast growth factor protein |
| 06/20/1990 | EP0373497A2 Dipeptide derivatives with an enzyme-inhibiting activity |
| 06/20/1990 | EP0373335A2 Serine protease inhibitor proteins, medicaments containing them, DNA sequences coding for these proteins and methods for producing these proteins, medicaments and DNA sequences |
| 06/20/1990 | EP0373260A1 Cyclosporin derivatives with modified "8-amino acid" |
| 06/20/1990 | EP0373218A1 Kidney growth accelerator and process for its preparation |
| 06/20/1990 | CN1043134A Anticoagulant peptides |
| 06/20/1990 | CN1043133A Imidazole-containing peptide and preparation thereof |
| 06/20/1990 | CN1043132A Dipeptid derivatives with enzymes inhibition |
| 06/20/1990 | CA2006060A1 Polypeptide-polymer conjugates active in wound healing |
| 06/20/1990 | CA2005600A1 Endothelial cell growth factor |
| 06/19/1990 | US4935526 Process for the purification of peptides |
| 06/19/1990 | US4935497 Dentin chondrogenic inductive agent |
| 06/19/1990 | US4935496 Mouse-human chimaeric immunoglobulin heavy chain specific for the call antigen |
| 06/19/1990 | US4935492 Cyclic analogs of atrial natriuretic peptides |
| 06/19/1990 | US4935491 Contraceptives with reduced side effects |
| 06/19/1990 | US4935465 Linked to linked to a water soluble polymer; decrease antigenicity; antiallergens |
| 06/19/1990 | US4935450 Cancer therapy system for effecting oncolysis of malignant neoplasms |
| 06/19/1990 | US4935405 Nor-statine and nor-cyclostatine polypeptides |
| 06/19/1990 | US4935404 Phosphorus containing peptides, pharmaceutical compositions and method of treating collagenolytic conditions |
| 06/19/1990 | US4935368 Process for producing tissue plasminogen activator |
| 06/19/1990 | US4935341 Oligonucleotide probes |
| 06/19/1990 | US4935238 Glycopeptidic substance; vancomycin class of antibiotics |
| 06/19/1990 | US4935234 Binding specific to glycoprotein of antigen and inhibiting adhesion; antiinflammatory agents |
| 06/19/1990 | US4935233 Covalently linked polypeptide cell modulators |
| 06/19/1990 | CA2005754A1 Combinations of angiotensin converting enzyme, and carbonic anhydrase, inhibitors for treating glaucoma |
| 06/19/1990 | CA2005753A1 Angiotensin converting enzyme inhibitors in the treatment of glaucoma |
| 06/19/1990 | CA2004846A1 N-substituted acylamino acid compounds, process for their production and their use |
| 06/19/1990 | CA1270598A1 Growth hormone releasing factor analogs and process therefore |
| 06/19/1990 | CA1270597A1 Thf compositions |
| 06/19/1990 | CA1270596A1 Peptide derivatives having a nitrogenous polycyclic structure and process for their preparation |
| 06/16/1990 | CA2005639A1 Lymphokine/cytokine genes |
| 06/16/1990 | CA2005459A1 Cloning and expression of transforming growth factor beta-2 |
| 06/16/1990 | CA2004830A1 Process for the separation and concentration of apolipoproteins |
| 06/16/1990 | CA2003886A1 Cloning and expression of simian transforming growth factor-beta 1 |
| 06/15/1990 | CA2005517A1 Lymphokine saf |
| 06/15/1990 | CA2005340A1 Retroviral protease inhibitors |
| 06/15/1990 | CA2005337A1 Use of peptide isosteres as retroviral protease inhibitors |
| 06/15/1990 | CA2005120A1 Tgf-beta 1/beta 2: a novel chimeric transforming growth factor-beta |
| 06/15/1990 | CA2005119A1 Use of basic amino acids to solubilize immunoglobulins |
| 06/14/1990 | WO1990006371A1 ANTI-INTERLEUKINE 1α AND 1β MONOCLONAL ANTIBODIES, METHOD FOR PRODUCING THE SAME AND APPLICATIONS OF SAID ANTIBODIES TO THE DETECTION OF INTERLEUKINES 1α AND 1β AND TO THERAPY |
| 06/14/1990 | WO1990006370A1 Synthetic interleukin-6 |
| 06/14/1990 | WO1990006365A1 Recombinant proteins with adipsin and complement d activities |
| 06/14/1990 | WO1990006362A1 Ancrod proteins, their production and use |
| 06/14/1990 | WO1990006323A2 Chimeric proteins incorporating a metal binding protein |
| 06/14/1990 | WO1990006321A1 Neutrophil-activating peptide-2 |
| 06/14/1990 | WO1990006136A1 Fast buccal tablet |
| 06/14/1990 | WO1990006135A1 Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon |
| 06/14/1990 | WO1990006134A1 Human platelet-specific antibodies |
| 06/14/1990 | WO1990006133A1 Heterobifunctional antibodies having specificity for platelets and thrombolytic agents |
| 06/14/1990 | WO1990006132A1 Method for the preparation of a library of antigenic peptide determinants, new peptides formed of or including the antigenic determinants obtained and application of the peptides particularly to diagnosis |
| 06/14/1990 | WO1990006129A1 Deletion analogues of magainin peptides |
| 06/14/1990 | WO1990006128A1 Methods and compositions for inhibiting platelet aggregation |
| 06/14/1990 | WO1990006127A1 STABILIZED COMPOSITION OF INTERLEUKIN-1$g(b) |
| 06/14/1990 | WO1990006102A1 Compound and method for the retardation of collagen cross-linking |
| 06/14/1990 | WO1990006047A2 Human high-affinity neurotransmitter uptake system |
| 06/14/1990 | WO1990003798A3 Targetting agents |
| 06/14/1990 | WO1990003164A3 Pharmaceutical formulations |
| 06/14/1990 | CA2005422A1 Enzyme-inhibiting amino acid derivatives, a process for the preparation thereof, agents containing these, and the use thereof |
| 06/14/1990 | CA2005247A1 Process and composition for increasing brain dopamine release |
| 06/13/1990 | EP0373070A1 Preparation of a library of peptidic antigenic determinants, new peptides built from or containing these determinants and use thereof, namely for diagnosis |
| 06/13/1990 | EP0373012A1 DNA encoding for factor IX or an analogous protein |